The Patent Finder

Alma Bio Therapeutics

Also on record
Records under this name other than patents Alma Bio Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Alma Bio Therapeutics

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,992,533Methods of Treatment of HLA-B27 Related Inflammatory Diseases and Compositions Related to Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,974,843DNA vaccines encoding heat shock proteins
Term ended
Term ended Jun 11, 2023 · USPTO record
Term endedTerm ended Jun 11, 2023USPTO record
US 8,058,254DNA vaccines encoding heat shock proteins
Term ended
Term ended May 21, 2023 · USPTO record
Term endedTerm ended May 21, 2023USPTO record
US 8,361,987DNA Vaccines Encoding Heat Shock Proteins
Term ended
Term ended May 21, 2023 · Medium confidence
Term endedTerm ended May 21, 2023Medium confidence
US 9,283,265DNA vaccines encoding heat shock proteins
Term ended
Term ended May 21, 2023 · USPTO record
Term endedTerm ended May 21, 2023USPTO record
US 10,226,517DNA Vaccines Encoding Heat Shock Proteins
Term ended
Ended no later than May 21, 2023 · Low confidence
Term endedEnded no later than May 21, 2023Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited